Inactive Instrument

Bayer Aktiengesellschaft Stock Other OTC

Equities

BAYRY

US0727303028

Pharmaceuticals

Sales 2024 * 47.18B 50.62B Sales 2025 * 48.08B 51.58B Capitalization 26.42B 28.35B
Net income 2024 * 2.08B 2.23B Net income 2025 * 3.17B 3.4B EV / Sales 2024 * 1.26 x
Net Debt 2024 * 33.11B 35.52B Net Debt 2025 * 29.67B 31.83B EV / Sales 2025 * 1.17 x
P/E ratio 2024 *
12.3 x
P/E ratio 2025 *
8.27 x
Employees -
Yield 2024 *
0.41%
Yield 2025 *
0.86%
Free-Float 99.97%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Bayer Aktiengesellschaft

Managers TitleAgeSince
Chief Executive Officer 57 23-03-31
Director of Finance/CFO 54 18-04-25
Chief Tech/Sci/R&D Officer 55 20-03-31
Members of the board TitleAgeSince
Director/Board Member 68 17-03-31
Director/Board Member 68 17-03-31
Director/Board Member 67 21-03-31
More insiders
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
More about the company